Importantly, a number of studies have shown changes in expression of ESCRT components in human cancer cells, including changes in expression of ESCRT-I components Tsg101 [59]–[62] and Vps37A [63], [64] and ESCRT-III components Chmp1A and CHMP3 [63], [65]. This evidence concerns the gene TSG101 and cancer.